Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Hematological Oncology|January 24, 2025
Comprehensive Characterization of Overt Myelofibrosis in an Asian Cohort: Phenotype, Mutation Landscape and Discordance Among Scoring SystemsYu-Sung Chang, Yu-Hung Wang, Chao-Hung Wei, et al.
British Journal of Haematology|November 18, 2025
Genomic and transcriptomic characterization of acute myeloid leukaemia with IL3RA overexpression: Prognostic and therapeutic implications revisitedChi-Yuan Yao, Chia-Lang Hsu, Yi-Tsung Yang, et al.
Blood Cancer Journal|January 4, 2023
Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AMLXavier Cheng-Hong Tsai, Kuo-Jui Sun, Min-Yen Lo, et al.
British Journal of Haematology|September 10, 2025
Taiwan consensus on pulmonary chronic graft-versus-host disease: A joint statement from the Taiwan Society of Blood and Marrow Transplantation (TBMT) and Taiwan Society of Pulmonary and Critical Care Medicine (TSPCCM)Xavier Cheng-Hong Tsai, Zong-Han Yao, Shu-Wei Chou, et al.
Annals of Hematology|November 12, 2021
Polatuzumab vedotin-based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experienceYu-Wen Wang, Xavier Cheng-Hong Tsai, Hsin-An Hou, et al.
Blood Cancer Journal|August 9, 2023
Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classificationWan-Hsuan Lee, Ming-Tao Tsai, Cheng-Hong Tsai, et al.
European Journal of Haematology|April 7, 2018
Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patientsFeng-Ming Tien, Hsin-An Hou, Cheng-Hong Tsai, et al.
Blood Cancer Journal|March 13, 2026
Prognostic implications of genetic and transcriptomic abnormalities in MDS according to IPSS-R, IPSS-M, and the International Consensus ClassificationWan-Hsuan Lee, Hsin-An Hou, Chien-Chin Lin, et al.
Blood Cancer Journal|April 9, 2024
Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasmsWan-Hsuan Lee, Chien-Chin Lin, Cheng-Hong Tsai, et al.
Ebiomedicine|October 27, 2018
Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndromeBor-Sheng Ko, Yu-Fen Wang, Jeng-Lin Li, et al.
Pageof 7